Anvisa Limits Polilaminina After 9 Deaths
Anvisa limited compassionate use of the experimental spinal cord drug polilaminina to 72-hour thoracic injuries after nine deaths; its maker sees no link. The post Anvisa Limits Polilaminina After 9 Deaths appeared first on The Rio Times.